{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T11:15:33Z","timestamp":1722942933981},"reference-count":30,"publisher":"Japanese Circulation Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2020,2,25]]},"DOI":"10.1253\/circj.cj-19-0974","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T17:04:17Z","timestamp":1579885457000},"page":"516-523","source":"Crossref","is-referenced-by-count":1,"title":["Baseline Characteristics of Elderly Japanese Patients Aged \u226575 Years With Non-Valvular Atrial Fibrillation and a History of Stroke\u3000\u2015 ANAFIE Registry \u2015"],"prefix":"10.1253","volume":"84","author":[{"given":"Kodai","family":"Kanemaru","sequence":"first","affiliation":[{"name":"Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Yoshimoto","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Inoue","sequence":"additional","affiliation":[{"name":"Saiseikai Toyama Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Yamashita","sequence":"additional","affiliation":[{"name":"The Cardiovascular Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Akao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Hospital Organization Kyoto Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotsugu","family":"Atarashi","sequence":"additional","affiliation":[{"name":"Minami Hachioji Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Toho University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Okumura","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Koretsune","sequence":"additional","affiliation":[{"name":"National Hospital Organization Osaka National Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Nippon Medical School Department of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Tsutsui","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Hirayama","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Osaka Police Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Yasaka","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine and Neurology, Cerebrovascular Center, National Hospital Organization Kyushu Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takenori","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Teramukai","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Kimura","sequence":"additional","affiliation":[{"name":"Medical Science Department, Daiichi Sankyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jumpei","family":"Kaburagi","sequence":"additional","affiliation":[{"name":"Medical Science Department, Daiichi Sankyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Takita","sequence":"additional","affiliation":[{"name":"Biostatistics & Data Management Department, Daiichi Sankyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Kusano","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Toyoda","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the All Nippon Atrial Fibrillation in the Elderly (ANAFIE) Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S. Epidemiology of atrial fibrillation: European perspective. <i>Clin Epidemiol<\/i> 2014; 6: 213\u2013220.","DOI":"10.2147\/CLEP.S47385"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Inoue H, Fujiki A, Origasa H, Ogawa S, Okumura K, Kubota I, et al. Prevalence of atrial fibrillation in the general population of Japan: An analysis based on periodic health examination. <i>Int J Cardiol<\/i> 2009; 137: 102\u2013107.","DOI":"10.1016\/j.ijcard.2008.06.029"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Pisters R, Lane DA, Marin F, Camm AJ, Lip GY. Stroke and thromboembolism in atrial fibrillation. <i>Circ J<\/i> 2012; 76: 2289\u20132304.","DOI":"10.1253\/circj.CJ-12-1036"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Iguchi Y, Kimura K, Shibazaki K, Aoki J, Kobayashi K, Sakai K, et al. Annual incidence of atrial fibrillation and related factors in adults. <i>Am J Cardiol<\/i> 2010; 108: 1129\u20131133.","DOI":"10.1016\/j.amjcard.2010.06.030"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Monte S, Macchia A, Pellegrini F, Romero M, Lepore V, D\u2019Ettorre A, et al. Antithrombotic treatment is strongly underused despite reducing overall mortality among high-risk elderly patients hospitalized with atrial fibrillation. <i>Eur Heart J<\/i> 2006; 27: 2217\u20132223.","DOI":"10.1093\/eurheartj\/ehl208"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GY. Underuse of oral anticoagulants in atrial fibrillation: A systematic review. <i>Am J Med<\/i> 2010; 123: 638\u2013645.","DOI":"10.1016\/j.amjmed.2009.11.025"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Heiat A, Gross CP, Krumholz HM. Representation of the elderly, women, and minorities in heart failure clinical trials. <i>Arch Intern Med<\/i> 2002; 162: 1682\u20131688.","DOI":"10.1001\/archinte.162.15.1682"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Herrera AP, Snipes SA, King DW, Torres-Viqil I, Goldberq DS, Weinberg AD. Disparate inclusion of older adults in clinical trials: Priorities and opportunities for policy and practice change. <i>Am J Public Health<\/i> 2010; 100: S105\u2013S112.","DOI":"10.2105\/AJPH.2009.162982"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kitzman DW, Rich MW. Age disparities in heart failure research. <i>JAMA<\/i> 2010; 304: 1950\u20131951.","DOI":"10.1001\/jama.2010.1592"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tahhan AS, Vaduganathan M, Greene SJ, Fonarow GC, Fiuzat M, Jessup M, et al. Enrollment of older patients, women, and racial and ethnic minorities in contemporary heart failure clinical trials: A systematic review. <i>JAMA Cardiol<\/i> 2018; 3: 1011\u20131019.","DOI":"10.1001\/jamacardio.2018.2559"},{"key":"11","unstructured":"11. WHO. World health statistics 2018: Monitoring health for the SDGs. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/272596\/9789241565585-eng.pdf (accessed June 15, 2019)."},{"key":"12","unstructured":"12. OECD. Elderly population. https:\/\/data.oecd.org\/pop\/elderly-population.htm#indicator-chart (accessed June 15, 2019)."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Inoue H, Yamashita T, Akao M, Atarashi H, Ikeda T, Okumura K, et al. Prospective observational study in elderly patients with non-valvular atrial fibrillation: Rationale and design of the All Nippon AF In the Elderly (ANAFIE) Registry. <i>J Cardiol<\/i> 2018; 72: 300\u2013306.","DOI":"10.1016\/j.jjcc.2018.02.018"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Koretsune Y, Yamashita T, Akao M, Atarashi H, Ikeda T, Okumura K, et al. Baseline demographics and clinical characteristics in the All Nippon AF in the Elderly (ANAFIE) Registry. <i>Circ J<\/i> 2019; 83: 1538\u20131545.","DOI":"10.1253\/circj.CJ-19-0094"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Lakshminarayan K, Solid CA, Collins AJ, Anderson DC, Herzog CA. Atrial fibrillation and stroke in the general Medicare population: A 10-year perspective (1992 to 2002). <i>Stroke<\/i> 2006; 37: 1969\u20131974.","DOI":"10.1161\/01.STR.0000230607.07928.17"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Toyoda K, Yasaka M, Iwade K, Nagata K, Koretsune Y, Sakamoto T, et al. Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease: A prospective, multicenter, observational study. <i>Stroke<\/i> 2008; 39: 1740\u20131745.","DOI":"10.1161\/STROKEAHA.107.504993"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. <i>JAMA<\/i> 2001; 285: 2864\u20132870.","DOI":"10.1001\/jama.285.22.2864"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation. <i>Chest<\/i> 2010; 137: 263\u2013272.","DOI":"10.1378\/chest.09-1584"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Pisters R, Lane DA, Nieuwlaat R, Vos C, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey. <i>Chest<\/i> 2010; 138: 1093\u20131100.","DOI":"10.1378\/chest.10-0134"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. JCS Joint Working Group. Guidelines for pharmacotherapy of atrial fibrillation (JCS 2013): Digest version. <i>Circ J<\/i> 2014; 78: 1997\u20132021.","DOI":"10.1253\/circj.CJ-66-0092"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Rosendaal FR, Cannegieter SC, van der Meer FJ, Bri\u00ebt E. A method to determine the optimal intensity of oral anticoagulant therapy. <i>Thromb Haemost<\/i> 1993; 69: 236\u2013239.","DOI":"10.1055\/s-0038-1651587"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Hori M, Matsumoto M, Tanahashi N, Momomura S, Uchiyama S, Goto S, et al. Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation: The J-ROCKET AF study. <i>Circ J<\/i> 2012; 76: 2104\u20132111.","DOI":"10.1253\/circj.CJ-12-0454"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Ogawa H, Senoo K, An Y, Shantsila A, Shantsila E, Lane DA, et al. Clinical features and prognosis in patients with atrial fibrillation and prior stroke: Comparing the Fushimi and Darlington AF Registries. <i>EBioMedicine<\/i> 2017; 18: 199\u2013203.","DOI":"10.1016\/j.ebiom.2017.03.022"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Mazurek M, Shantsila E, Lane DA, Wolff A, Proietti M, Lip GYH. Secondary versus primary stroke prevention in atrial fibrillation: Insights from the Darlington Atrial Fibrillation Registry. <i>Stroke<\/i> 2017; 48: 2198\u20132205.","DOI":"10.1161\/STROKEAHA.116.016146"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Toyoda K, Arihiro S, Todo K, Yamagami H, Kimura K, Furui E, et al. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: The SAMURAI-NVAF study. <i>Int J Stroke<\/i> 2015; 10: 836\u2013842.","DOI":"10.1111\/ijs.12452"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A meta-analysis of randomised trials. <i>Lancet<\/i> 2014; 383: 955\u2013962.","DOI":"10.1016\/S0140-6736(13)62343-0"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Yoshimura S, Koga M, Sato S, Todo K, Yamagami H, Kumamoto M, et al. Two-year outcomes of anticoagulation for acute ischemic stroke with nonvalvular atrial fibrillation: SAMURAI-NVAF Study. <i>Circ J<\/i> 2018; 82: 1935\u20131942.","DOI":"10.1253\/circj.CJ-18-0067"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Seiffge DJ, Paciaroni M, Wilson D, Koga M, Macha K, Cappellari M, et al. Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation. <i>Ann Neurol<\/i> 2019; 85: 823\u2013834.","DOI":"10.1002\/ana.25489"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Haas S, Ten Cate H, Accetta G, Angchaisuksiri P, Bassand JP, Camm AJ, et al. Quality of vitamin K antagonist control and 1-year outcomes in patients with atrial fibrillation: A global perspective from the GARFIELD-AF Registry. <i>PLoS One<\/i> 2016; 11: e0164076.","DOI":"10.1371\/journal.pone.0164076"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Suzuki S, Yamashita T, Okumura K, Atarashi H, Akao M, Ogawa H, et al. Incidence of ischemic stroke in Japanese patients with atrial fibrillation not receiving anticoagulation therapy: Pooled analysis of the Shinken Database, J-RHYTHM Registry, and Fushimi AF Registry. <i>Circ J<\/i> 2015; 79: 432\u2013438.","DOI":"10.1253\/circj.CJ-14-1131"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/84\/3\/84_CJ-19-0974\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T22:21:27Z","timestamp":1582928487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/84\/3\/84_CJ-19-0974\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,25]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-19-0974","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"type":"print","value":"1346-9843"},{"type":"electronic","value":"1347-4820"}],"subject":[],"published":{"date-parts":[[2020,2,25]]}}}